Your browser is no longer supported. Please, upgrade your browser.
Settings
IBB iShares Nasdaq Biotechnology daily Stock Chart
IBB [NASD]
iShares Nasdaq Biotechnology
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.40%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month1.06%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter7.82%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio5.16 Perf Half Y8.18%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year1.41%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range239.90 - 303.43 Perf YTD10.05%
Dividend0.63 P/FCF- EPS past 5Y- ROI- 52W High-3.85% Beta-
Dividend %0.22% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low21.61% ATR4.10
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)52.99 Volatility1.23% 1.29%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.80 Prev Close287.49
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.14M Price291.74
Recom- SMA200.48% SMA50-0.34% SMA2003.33% Volume914,173 Change1.48%
Apr-13-17 05:58PM  Final Trade: C, IWM & more CNBC Videos
05:00PM  The next billion dollar drugs: 3 trades CNBC Videos
01:53PM  Health Care and Technology: A Perfect Combo for Stock Investors Now? Zacks
Apr-12-17 05:11PM  Beyond Trump, markets primed for pullback: Strategist CNBC Videos
Apr-06-17 01:16PM  Biotech: The Canary in the Coal Mine Investopedia
Apr-04-17 12:24PM  There's Value in Healthcare ETFs Investopedia
Mar-31-17 01:18PM  About that GOP health reform, it was no big deal for health-care stocks in the first quarter CNBC
Mar-29-17 08:32AM  These Charts Suggest Biotech Is Heading Higher Investopedia
Mar-28-17 05:00PM  5 ways to trade today's market rally CNBC Videos
Mar-27-17 05:33PM  Biotech Stocks Strong In Weak Market Investopedia
05:00PM  Trading a losing streak: 6 plays CNBC Videos
01:56PM  Here's who has the most to lose if the government starts negotiating drug prices Business Insider
Mar-24-17 04:46PM  Stock Market Video Analysis Wk Ending 3/24/17
04:35PM  Market Shakes As Republicans Accept Defeat On Healthcare Bill Benzinga
09:28AM  The Market In 5 Minutes Benzinga
Mar-23-17 01:22PM  Stalling Healthcare Reform May Be Holding Up the Rally
10:57AM  Biotechs Back in the Doghouse After Failed Rally at Investopedia
10:06AM  Health Care Vote Looms With Market Focused On Possible Tax Policy Implications
Mar-22-17 09:58AM  And Along Came A Spider...With Potential Benefits For Stroke Victims
09:30AM  Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
Mar-21-17 05:02PM  Trump goes to the Hill, stocks slammed
04:28PM  Stock Market Video Analysis 3/21/17
10:57AM  Biotech Momentum Outweighs Pharma 'Red Flag' In ETF Upgrade
10:43AM  Trump says he wants to tackle drug pricing in the GOP's Obamacare replacement plan
07:00AM  Biotech Bull Making a Comeback
Mar-19-17 10:04PM  How Much You'd Spend On Healthcare Under New GOP Plan, By Income
01:21PM  Businesses Will Be Impacted By Trumpcare
Mar-17-17 01:43PM  The Top 4 ETFs to Track the Nasdaq in 2017 at Investopedia
Mar-15-17 04:36PM  Stock Market Video Analysis
08:26AM  Biotech is Bubbling Up
Mar-13-17 05:46PM  Time to Buy Biotech ETFs?
02:08PM  Biotech stocks are turning bullishhere's how to profit
12:23PM  Pres. Trump nominates Dr. Scott Gottlieb to run FDA
Mar-10-17 04:54PM  Stock Market Video Analysis
11:32AM  Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump
Mar-09-17 05:14PM  Biotech Reporter Adam Feuerstein Will Be On Benzinga's PreMarket Prep Friday Morning
01:25PM  What Does Gilead Need? Stable HCV Scripts and "a String of Pearls" at Barrons.com
11:51AM  GOP Health Plan: Winners, Losers & Who Knows at Barrons.com
08:00AM  Trending: Aerospace and Defense Advance as Trump Promises Military Spending Boost
Mar-07-17 05:07PM  3 large-cap buys to play strength in health care: Ross
05:00PM  5 ways to trade health care after AHC unveil
03:21PM  Analysts Scratch Their Heads Over Trump Drug Price Tweet at The Wall Street Journal
01:05PM  Analyst: Not 'worst case scenario' for drug industry
12:11PM  Drug innovators will continue to do well: Isaly
11:32AM  Healthcare Stocks Fall, But Still Appear Strong at Investopedia
10:37AM  Will Obamacare Repeal Make Healthcare Stocks Sick? at Barrons.com
09:48AM  Trump's Latest Drug Pricing Tweet Hits Biotech Stocks at The Wall Street Journal
09:18AM  Trump tweets that he's working on a 'new system where there will be competition in the drug industry'
Mar-01-17 07:00PM  Trades to make following Trump's speech at CNBC
05:32PM  Did Biotech Get a Presidential Pardon? at Barrons.com
05:15PM  Drugs stocks shrug off Trump warning
05:00PM  8 trades following Trump's congressional speech
12:46PM  Infrastructure, Immigration And 7 Key Takeaways From Trump's Address To Congress
11:55AM  Gilead Sciences: M&A to the Rescue? at Barrons.com
Feb-28-17 02:17PM  Kite CEO: May see cancer drug approval by end of year
02:14PM  Two biotechs taking it on the chin
09:09AM  Alnylam Pharmaceuticals Advances Its Patisiran Research Program
Feb-27-17 04:25PM  Market Action Shifts, but Only Slightly
03:38PM  Biotech Surges. Is the Sector Breaking Out? at Investopedia
Feb-24-17 04:13PM  Heres how analysts say you should trade Trumps speech to Congress at MarketWatch
12:54PM  8 Signs the Trump Trade Is Crumbling at The Wall Street Journal
Feb-21-17 05:21PM  [$$] Why Biotech Stocks Are Finally Set to Break Out at Barrons.com
Feb-19-17 05:15PM  Barron's Picks And Pans: General Motors, Hess, Biotechs And More
Feb-17-17 04:35PM  Stock Market Video Analysis 2/17/17
11:34AM  Biotech ETF Investors are Still on the Sidelines at Investopedia
07:37AM  Prolia Expected to Be a Significant Growth Driver for Amgen in 2017
Feb-15-17 05:19PM  Biotech boom?
04:31PM  Stock Market Video Analysis 2/15/17
02:44PM  Two Great Stock Ideas in the IBB Biotech ETF at Investopedia
09:44AM  Gilead Sciences: Its Game to Lose? at Barrons.com
Feb-14-17 03:07PM  The New Normal: Is The Current Bull Market Trump Resistant?
Feb-13-17 05:58PM  Final Trade: QCOM, TWTR & more
Feb-10-17 10:17AM  Why Gilead's Disastrous Forecast is Good News for Biotech at Barrons.com
Feb-08-17 05:45PM  Gilead tanks on weak forecast
04:00PM  How To Maximize Biotech Returns Under Donald Trump at Forbes
01:28PM  Gilead: Where's the Bottom? at Barrons.com
Feb-07-17 07:47PM  Healthcare Stocks: The Buying Opportunity of the Year?
05:30PM  White House says Trump wants Medicare negotiation on drug...
08:15AM  3 Top Stocks to Buy for Your Kids at Motley Fool
Feb-06-17 05:01PM  Buy safety in sideways tape?
12:40PM  Priced like an automaker, sputtering Gilead shares lure value bets
Feb-03-17 03:15PM  Amgen: Who Says Biotech's Dead? at Barrons.com
Feb-02-17 07:20PM  Fast Money traders discuss how to trade Amgen and Amazon earnings at CNBC
05:00PM  How to trade Amgen/Amazon earnings: 5 trades
Jan-31-17 05:28PM  Making pharma great again?
03:06PM  Not all bad news with Trump pharma meeting?
01:06PM  Klain: Pharma will be net winner in exchange with Trump a...
Jan-27-17 04:30PM  What Lies Ahead for Biotech ETFs in Trump Era?
Jan-26-17 09:50AM  Why Biogen is Flying at Barrons.com
Jan-25-17 05:08PM  Fundstrat's Lee says to buy C.R.A.P. at Dow 20K
07:40AM  Here's How to Play the Biotech Rebound
Jan-24-17 05:05PM  Inside Amgens Oncology Segment: Multiple Investigational Therapies in 2017
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.